Suppr超能文献

肾原发性血管肉瘤:病例报告及文献综述

Primary Angiosarcoma of the Kidney: Case Report and Comprehensive Literature Review.

作者信息

Boni Andrea, Cochetti Giovanni, Sidoni Angelo, Bellezza Guido, Lepri Emanuele, Giglio Andrea De, Turco Morena, Vermandois Jacopo Adolfo Rossi De, Zingaro Michele Del, Cirocchi Roberto, Mearini Ettore

机构信息

Department of Surgical and Biomedical Sciences, Urologic Clinic, University of Perugia, University Hospital of Perugia, Perugia, Italy.

Department of Experimental Medicine, Section of Anatomic Pathology and Histology, Perugia Medical School, University of Perugia, Perugia, Italy.

出版信息

Open Med (Wars). 2019 Jul 31;14:443-455. doi: 10.1515/med-2019-0048. eCollection 2019.

Abstract

PURPOSE

Angiosarcoma (AS) is an aggressive malignant tumour of endothelial origin, most frequently compelling the skin. The kidney is a rare site of primary occurrence of AS with a quite challenging diagnosis and poor prognosis, mainly due to its raw metastasising power. We described our first case of AS treatment. A comprehensive literature review in this field is also carried out.

PATIENTS AND METHODS

We report the case of a 56-years-old man with radiological appearance of an 11 cm poor vascularised left renal mass. The pre-operative imaging ruled out distant metastases and inferior vena cava thrombosis. Thus, after radioembolization, we performed a transperitoneal open radical nephrectomy with regional lymphadenectomy with the removal of the middle portion of the ileo-psoas muscle, followed by two lines of adjuvant chemotherapy. We analysed all the papers concerning primary kidney AS until December 2018.

RESULTS

Estimated intraoperative blood loss was 200 mL with an operative time of 100 minutes. No postoperative complications were recorded, with the patient discharge in the 8th postoperative day. The pathological assessment showed a pT3a N0, M0 tumour compatible with AS of the kidney. An immune-histochemical study showed a vascular positive for CD31, CD34, Fli-1 with a Ki-67/Mib 1 of 50%. One month after surgery the patient began adjuvant chemotherapy with gemcitabine. After 45 days from surgery, a Computed Tomography scan showed lung and liver metastases with disease relapse in the left kidney lodge. The response to the first-line treatment was excellent, unlike the second-line, encountering a chemo-refractory disease. The cancer-specific survival was of 15 months. We included 66 cases in our review.

CONCLUSION

This is the first case of treatment of kidney AS performed at our Institute. Our findings added new information about the unclear biology and progression of this subset of tumours, demonstrating an abysmal prognosis.

摘要

目的

血管肉瘤(AS)是一种起源于内皮细胞的侵袭性恶性肿瘤,最常见于皮肤。肾脏是AS原发性发生的罕见部位,诊断颇具挑战性且预后较差,主要因其具有较强的转移能力。我们描述了首例AS治疗病例。同时还对该领域进行了全面的文献综述。

患者与方法

我们报告了一例56岁男性患者,其左肾有一个11厘米、血管化不良的肿块,影像学表现如此。术前影像检查排除了远处转移和下腔静脉血栓形成。因此,在进行放射性栓塞后,我们实施了经腹开放性根治性肾切除术及区域淋巴结清扫术,切除了髂腰肌中间部分,随后进行了两线辅助化疗。我们分析了截至2018年12月所有关于原发性肾AS的论文。

结果

估计术中失血200毫升,手术时间为100分钟。未记录到术后并发症,患者于术后第8天出院。病理评估显示为pT3a N0、M0肿瘤,符合肾AS。免疫组织化学研究显示血管CD31、CD34、Fli - 1呈阳性,Ki - 67/Mib 1为50%。术后1个月患者开始使用吉西他滨进行辅助化疗。术后45天,计算机断层扫描显示肺部和肝脏转移,左肾部位疾病复发。一线治疗反应良好,而二线治疗则遇到化疗难治性疾病。癌症特异性生存期为15个月。我们的综述纳入了66例病例。

结论

这是我们研究所进行的首例肾AS治疗病例。我们的研究结果为这类肿瘤不明的生物学特性和进展增添了新信息,显示出预后极差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73da/6689208/9a439203596f/med-14-443-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验